|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A phase II evaluation of nanoparticle, albumin-bound (nab) pacl- itaxel in the treatment of recurrent or persistent plati- num-resistant ovarian, fallopian tube, or primary perito- neal cancer: a Gynecologic Ontology Group study显示文摘 | Coleman RL Brady WE McMeekin DS | 2011 | Gynecol Oncol2011，122，1： | 1 |
| 2 | A phase Ⅱ evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian,fallopian or primary peritoneal cancer:a gynecologic oncology group study显示文摘 | Rocereto TF Brady WE Shahin MS | 2010 | Gynecol Oncol2010，116，： | 1 |
| 3 | Histologic effects ofmedroxyprogesterone acetate on endometrioid endometrialadenocarcinoma : a gynecologic oncology group study 显示文摘 | Zaino RJ Brady WE Todd W | 2014 | Int JGynecol Pathol2014，33，6： | 1 |
| 4 | Comparison of meth- ods to estimate health state utilities for ovarian cancer us- ing quality of life data: a Gynecologic Oncology Group study显示文摘 | Hess LM Brady WE Havrilesky LJ | 2013 | Gynecol Oncol2013，128，2： | 1 |
| 5 | A phase Ⅱ evaluation of nanoparticle,albumin-bound(nab)paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian,fallopian tube,or primary peritoneal cancer:a Gynecologic Oncology Group study显示文摘 | Coleman RL Brady WE McMeekin DS | 2011 | Gynecol Oncol2011，122，1： | 1 |
| 6 | Gleevec-mediated inhibition of RadSl expression and enhancement of tumor cell radiosensitivity显示文摘 | Russell JS Brady K Burgan WE | 2003 | Cancer Res2003，63，21： | 1 |
| 7 | Alcohol consumption and cardiovascular risk in hypertensives with left ventricular hypertrophy:the LIFE study显示文摘 | Reims HM Kjeldsen SE Brady WE | 2004 | Journal of Human Hypertension2004，18，6： | 1 |
| 8 | Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase Trial of the Gynecologic Cancer Intergroup 显示文摘 | Bookman MA Brady MF McGuire WE | 2009 | J Clin Oncol2009，27，9： | 1 |
| 9 | A phase II study of a urokinase-derived peptide (A6) in the treatment of per- sistent or recurrent epithelial ovarian,fallopian tube, or pri- mal-- peritoneal carcinoma:a Gynecologic Oncology Group study显示文摘 | Gold MA Brady WE Lankes HA | 2012 | Gynecol Oncol2012，125，3： | 1 |
| 10 | Cyclophosphamide and cisplatin compared with paclitaxei and cisplatin in patients with stage Ill and stage IV ovarian cancer显示文摘 | McGuire WE Hoskins WJ Brady MF | 1996 | N Engl J Med1996，334，1： | 1 |
| 11 | Cadherins, catenins and cell cycle regulators: impact on survival in a Gynecologic Oncology Group phase II endometrial cancer trial 显示文摘 | Singh M Darcy KM Brady WE | 2011 | GynecolOncol2011，123，2： | 1 |
| 12 | Selumetinib in women with recurrent low-grade serous carcinoma of the o- vary or peritoneum : an open -label,single -arm, phase 2 study显示文摘 | Farley J Brady WE Vathipadiekal V | 2013 | Lancet Oncol2013，14，2： | 1 |
| 13 | Phylogeography and genetic ancestry of tigers(Panthera tigris)显示文摘 | Luo S J Kim JH Johnson WE van der Walt J Martenson J Yuhki N Miquelle DG Uphyrkina O Goodrich JM Quigley HB Tilson R Brady G Martelli P Subramaniam V McDougal C Hean S Huang SQ Pan W Karanth UK Sunquist M Smith JLD O'Brien SJ | | 0，，： | 1 |
| 14 | Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum:an open-label,single-arm,phase 2 study显示文摘 | Farley J Brady WE Vathipadiekal V | 2013 | Lancet Oncol2013，14，2： | 1 |
| 15 | A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: a Gynecologic Oncology Group study 显示文摘 | Coleman RL Brady WE McMeekin DS | 2011 | Gynecol Oncol2011，122，1： | 1 |
| 16 | A phase II evaluation of pazopanib in the treatment of recurrent or persistent eareinosarcoma of the uterus: a gynecologic oneology group study显示文摘 | Campos SM Brady WE Moxley KM et el | 2014 | Gynecol Oneol2014，133，3： | 1 |
| 17 | A phase 11 evaluation of nanoparticle, albumin-bound (nab) paclitax- el in the treatment of recurrent or persistent platinum-re- sistant ovarian,fallopian tube,or primary peritoneal can- cer:a Gynecologic Oncology Group study显示文摘 | Coleman RL Brady WE McMeekin DS | 2011 | GynecolOncol2011，122，1： | 1 |
| 18 | The effect of a losartan-based treatment regimen on isolated systolic hypertension显示文摘 | Cushman WC Brady WE Gazdick LP | | 0，，： | 1 |
| 19 | Efficacy of ultrasonic cleaning显示文摘 | Weller RN Brady JM Bernier WE | 1980 | J Endod1980，6，7： | 1 |
| 20 | Prognostic relevance of c-Myc gene amplification and polysomy for chromosome 8 in suhoptimally-resected, advanced stage epithelial ovarian cancers: a Gynecologic Oncology Group study 显示文摘 | Darcy KM Brady WE Blancato JK | 2009 | Gynecol Oncol2009，114，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员